Tectonic Therapeutic, Inc.
TECX
$17.08
$1.7211.20%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 18.40% | 144.74% | 121.59% | 168.69% | 133.08% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 95.53% | 41.10% | 49.25% | 94.16% | 7.43% |
| Operating Income | -95.53% | -41.10% | -49.25% | -94.16% | -7.43% |
| Income Before Tax | -50.01% | -4.50% | -57.24% | -76.22% | -21.20% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -57.71% | -4.50% | -57.24% | -76.22% | -21.20% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -57.71% | -4.50% | -57.24% | -76.22% | -21.20% |
| EBIT | -95.53% | -41.10% | -49.25% | -94.16% | -7.43% |
| EBITDA | -98.39% | -42.47% | -49.79% | -97.20% | -8.03% |
| EPS Basic | 75.35% | 91.55% | 85.79% | 84.22% | 49.00% |
| Normalized Basic EPS | 76.55% | 91.55% | 85.79% | 84.22% | 49.00% |
| EPS Diluted | 75.35% | 91.55% | 85.79% | 84.22% | 49.00% |
| Normalized Diluted EPS | 76.55% | 91.55% | 85.79% | 84.22% | 49.00% |
| Average Basic Shares Outstanding | 539.75% | 1,136.77% | 1,006.57% | 1,016.59% | 137.62% |
| Average Diluted Shares Outstanding | 539.75% | 1,136.77% | 1,006.57% | 1,016.59% | 137.62% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |